Impotence

New England Journal of Medicine

Volumn 321, Issue 24, 1989, Pages 1648-1659

  Krane, Robert J ^a   Goldstein, Irwin ^a   de Tejada, Iñigo Saenz ^a  

^a Abdominal Imaging   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PAPAVERINE; PHENTOLAMINE; YOHIMBINE;

DIABETES MELLITUS; HUMAN; HYPERPROLACTINEMIA; HYPOGONADISM; IMPOTENCE; MALE; NEUROPATHY; ORAL DRUG ADMINISTRATION; PENIS ERECTION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REVIEW;

EID: 0024785870     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198912143212406     Document Type: Review

References (150)

1. Shabsigh R, Fishman IJ, Scott FB. Evaluation of erectile impotence. Urology 1988; 32: 83–90.
2. Furlow WL. Prevalence of impotence in the United States. Med Aspects Hum Sex 1985; 19: 13–6.
3. Kinsey achéal, Pomeroy W, Martin C. Age and sexual outlet. In: Kinsey achéal, Pomeroy WB, Martin CE, eds. Sexual behavior in the human male. Philadelphia: W.B. Saunders, 1948:218–62.
4. McCulloch DK, Campbell IW, Wu FC, Prescott RJ, Clarke BF. The prevalence of diabetic impotence. Diabetologia 1980; 18: 279–83.
5. National Center for Health Statistics, Nelson C, McLemore T. The National Ambulatory Medical Care Survey: United States 1975—81 and 1985 trends. Vital and health statistics. Series 13. No. 93. Washington, D.C.: Government Printing Office, 1988. (DHHS publication no. (PHS) 88–1754.)
6. National Center for Health Statistics. National Hospital Discharge Survey, 1985. Bethesda, Md.: Department of Health and Human Services. 1989. (DHHS publication no. 87–1751.)
7. Goldstein AMB, Meehan JP, Zakhary R, Buckley PA, Rogers FA. New observations on microarchitecture of corpora cavernosa in man and possible relationship to mechanism of erection. Urology 1982; 3: 259–66.
8. Lue TF. Tanagho EA. Functional anatomy and mechanism of penile erection. In: Tanagho EA, Lue TF, McClure RD, eds. Contemporary management of impotence and infertility. Baltimore: Williams & Wilkins, 1988:39–50.
9. Puech-Leao P, Reis JM, Glina S, Reichelt achéal. Leakage through the crural edge of the corpus cavernosum: diagnosis and treatment. Eur Urol 1987; 13: 163–5.
10. de Groat WC, Steers WD. Neuroanatomy and neurophysiology of penile erection. In: Tanagho EA, Lue TF, McClure RD, eds. Contemporary management of impotence and infertility. Baltimore: Williams & Wilkins, 1988:3–27.
11. Weiss HD. The physiology of human penile erection. Ann Intern Med 1972; 76: 793–9.
12. Hart BL, Leedy MG. Neurological bases of male sexual behavior: a comparative analysis. In: Adler N, Pfaff D, Goy RW, eds. Reproduction. Vol. 7 of Handbook of behavioral neurobiology. New York: Plenum, 1985:373–422.
13. MacLean PD, Ploog DW. Cerebral representation of penile erection. J Neurophysiol 1962; 25: 29–55.
14. MacLean PD, Denniston RH, Dua S. Further studies on cerebral representation of penile erection: caudal thalamus, midbrain, and pons. J Neurophysiol 1963; 26: 274–93.
15. Dua S, MacLean PD. Localization of penile erection in medial frontal lobe. Am J Physiol 1964; 207: 1425–34.
16. Saper CB, Loewy AD, Swanson LW, Cowan WM. Direct hypothalamoautonomic connections. Brain Res 1976; 117: 305–12.
17. Swanson LW, Sawchenko PE. Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. Annu Rev Neurosci 1983; 6: 269–324.
18. Saenz de Tejada I, Goldstein I, Blanco R, Cohen RA, Krane RJ. Smooth muscle of the corpora cavernosae: role in penile erection. Surg Forum 1985; 36: 623–4.
19. Lue TF, Tanagho EA. Physiology of erection and pharmacological management of impotence. J Urol 1987; 137: 829–36.
20. McConnell J, Benson GS. Innervation of human penile blood vessels. Neurourol Urodynamics 1982; 1: 199–210.
21. Benson GS, McConnell J, Lipshultz LI, Corriere JN Jr, Wood J. Neuromorphology and neuropharmacology of the human penis: an in vitro study. J Clin Invest 1980; 65: 506–13.
22. Benson GS. Penile erection: in search of a neurotransmitter. World J Urol 1983; 1: 209–12.
23. Adrian TE, Gu J, Allen JM, Tatemoto K, Polak JM, Bloom SR. Neuropeptide Y in the human male genital tract. Life Sci 1984; 35: 2643–8.
24. Polak JM, Gu J, Mina S, Bloom SR. Vipergic nerves in the penis. Lancet 1981; 2: 217–9.
25. Hedlund H, Andersson K-E. Comparison of the responses to drugs acting on adrenoreceptors and muscarinic receptors in human isolated corpus cavernosum and cavernous artery. J Auton Pharmacol 1985; 5: 81–8.
26. Kimoto Y, Ito Y. Autonomic innervation of the canine penile artery and vein in relation to neural mechanisms involved in erection. Br J Urol 1987; 59: 463–72.
27. Saenz de Tejada I, Blanco R, Goldstein I, et al. Cholinergic neurotransmission in human corpus cavernosum. I. Responses of isolated tissue. Am J Physiol 1988; 254: H459–H467.
28. Blanco R, Saenz de Tejada I, Goldstein I, Krane RJ, Wotiz HH, Cohen RA. Cholinergic neurotransmission in human corpus cavernosum. II. Acetylcholine synthesis. Am J Physiol 1988; 254: H468–H472.
29. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373–6.
30. Vanhoutte PM. The end of the quest? Nature 1987; 327: 459–60.
31. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411–5.
32. Saenz de Tejada I, Carson MP, Traish A, Eastman EH, Goldstein I. Role of endothelin in the local control of penile smooth muscle tone. J Vasc Med Biol 1989; 1: 112. abstract.
33. van Grondelle A, Worthen GS, Ellis D, et al. Altering hydrodynamic variables influences PGI2 production by isolated lungs and endothelial cells. J Appl Physiol 1984; 57: 388–95.
34. Rubanyi GM, Romero JC, Vanhoutte PM. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 1986; 250: H1145–H1149.
35. Herbert J. The role of the dorsal nerves of the penis in the sexual behaviour of the male rhesus monkey. Physiol Behav 1973; 10: 293–300.
36. Dahlof LG, Larsson K. Interactional effects of pudendal nerve section and social restriction on male rat sexual behavior. Physiol Behav 1976; 16: 757–62.
37. Torrens MJ. Neurologic and neurosurgical disorders associated with impotence. In: Krane RJ, Siroky MB, Goldstein I, eds. Male sexual dysfunction. Boston: Little, Brown, 1983:55–61.
38. Amelar RD, Dubin L. Sexual function and fertility in paraplegic males. Urology 1982; 20: 62–5.
39. Lepor H, Gregerman M, Crosby R, Mostofi FK, Walsh PC. Precise localization of the autonomic nerves from the pelvic plexus to the corpora cavernosa: a detailed anatomical study of the adult male pelvis. J Urol 1985; 133: 207–12.
40. Eggleston JC, Walsh PC. Radical prostatectomy with preservation of sexual function: pathological findings in the first 100 cases. J Urol 1985; 134: 1146–8.
41. Catalona WJ, Dresner SM. Nerve-sparing radical prostatectomy: extraprostatic tumor extension and preservation of erectile function. J Urol 1985; 134: 1149–51.
42. Wilson JD, George FW, Griffin JE. The hormonal control of sexual development. Science 1981; 211: 1278–84.
43. Bancroft J, Wu FC. Changes in erectile responsiveness during androgen replacement therapy. Arch Sex Behav 1983; 12: 59–66.
44. Kwan M, Greenleaf WJ, Mann J, Crapo L, Davidson JM. The nature of androgen action on male sexuality: a combined laboratory-self-report study on hypogonadal men. J Clin Endocrinol Metab 1983; 57: 557–62.
45. Sar M, Stumpf WE. Distribution of androgen target cells in rat forebrain and pituitary after (3H)-dihydrotestosterone administration. J Steroid Biochem 1977; 8: 1131–5.
46. Sar. Androgen concentration in motor neurons of cranial nerves and spinal cord. Science 1977; 197: 77–9.
47. Rees HD, Michael RP. Brain cells of the male rhesus monkey accumulate 3H-testosterone or its metabolites. J Comp Neurol 1982; 206: 273–7.
48. Spark RF, White RA, Connolly PB. Impotence is not always psychogenic: newer insights into hypothalamic-pituitary-gonadal dysfunction. JAMA 1980; 243: 750–5.
49. Franks S, Jacobs HS, Martin N, Nabarro JD. Hyperprolactinaemia and impotence. Clin Endocrinol (Oxf) 1978; 8: 277–87.
50. Carter JN, Tyson JE, Tolis G, Van Vliet S, Faiman C, Friesen HG. Prolactin-secreting tumors and hypogonadism in 22 men. N Engl J Med 1978; 299: 847–52.
51. Pogach LM, Vaitukaitis JL. Endocrine disorders associated with erectile dysfunction. In: Krane RJ, Siroky MB, Goldstein I, eds. Male sexual dysfunction. Boston: Little, Brown, 1983:63–76.
52. von Euler US. Quantitation of stress by catecholamine analysis. Clin Pharmacol Ther 1964; 5: 398–404.
53. Benard F, Stief CG, Bosch R, et al. Systemic infusion of epinephrine: its effect on erection. In: Proceedings of the Sixth Biennial International Symposium for Corpus Cavernosum Revascularization and Third Biennial World Meeting on Impotence, Boston, Massachusetts, October 6, 1988:16.
54. Diederichs W, Stief CG, Lue TF, Tanagho EA. Sympathetic inhibition of papaverine-induced erection. In: Proceedings of the Sixth Biennial International Symposium for Corpus Cavernosum Revascularization and Third Biennial World Meeting on Impotence, Boston, Massachusetts, October 6, 1988:79.
55. Smith AD. Psychologic factors in the multidisciplinary evaluation and treatment of erectile dysfunction. Urol Clin North Am 1988; 15: 41–51.
56. Virag R, Bouilly P, Frydman D. Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men. Lancet 1985; 1: 181–4.
57. Ruzbarsky V, Michal V. Morphologic changes in the arterial bed of the penis with aging: relationship to the pathogenesis of impotence. Invest Urol 1977; 15: 194–9.
58. Michal V. Arterial disease as a cause of impotence. Clin Endocrinol Metab 1982; 11: 725–48.
59. Sharlip ID. Penile arteriography in impotence after pelvic trauma. J Urol 1981; 126: 477–81.
60. Goldstein I, Feldman MI, Deckers PJ, Babayan RK, Krane RJ. Radiation-associated impotence: a clinical study of its mechanism. JAMA 1984; 251: 903–10.
61. Cerami A, Vlassara H, Brownlee M. Glucose and aging. Sci Am 1987; 256(5):90–6.
62. Hayashi K, Takamizawa K, Nakamura T, Kato T, Tsushima N. Effects of elastase on the stiffness and elastic properties of arterial walls in cholesterol-fed rabbits. Atherosclerosis 1987; 66: 259–67.
63. Fischer GM, Swain ML, Cherian K. Increased vascular collagen and elastin synthesis in experimental atherosclerosis in the rabbit: variation in synthesis among major vessels. Atherosclerosis 1980; 35: 11–20.
64. Montague DK. Disorders of male sexual dysfunction. Chicago: Year Book, 1988:154–91.
65. Hinman F Jr. Priapism: reasons for failure of therapy. J Urol 1960; 83: 420–8.
66. Slag MF, Morley JE, Elson MK, et al. Impotence in medical clinic outpatients. JAMA 1983; 249: 1736–40.
67. Segraves RT, Madsen R, Carter CS, et al. Erectile dysfunction associated with pharmacological agents. In: Segraves RT, Schoenberg HW, eds. Diagnosis and treatment of erectile disturbances: a guide for clinicians. New York: Plenum, 1985:22–63.
68. Wein AJ, Van Arsdalen KN. Drug-induced male sexual dysfunction. Urol Clin North Am 1988; 15: 23–31.
69. Penden NR, Cargill JM, Browning MC, Saunders JH, Wormsley KG. Male sexual dysfunction during treatment with cimetidine. Br Med J 1979; 1: 659.
70. Ellenberg M. Impotence in diabetes: the neurologic factor. Ann Intern Med 1971; 75: 213–9.
71. Kolodny RC, Kahn CB, Goldstein HH, Barnett DM. Sexual dysfunction in diabetic men. Diabetes 1974; 23: 306–9.
72. Lehman TP, Jacobs JA. Etiology of diabetic impotence. J Urol 1983; 129: 291–4.
73. Saenz de Tejada I, Goldstein I, Azadzoi K, Krane RJ, Cohen RA. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 1989; 320: 1025–30.
74. Barry JM, Hodges CV. Impotence: a diagnostic approach. J Urol 1978; 119: 575–8.
75. Padma-Nathan H, Goldstein I, Krane RJ. Evaluation of the impotent patient. Semin Urol 1986; 4: 225–32.
76. Krane RJ. Sexual function and dysfunction. In: Walsh PC, Gittes RF, Perlmutter AD, Stamey TA, eds. Campbell's urology. Vol. 1. Philadelphia: W.B. Saunders, 1986; 13:700–35.
77. Melman A, Kaplan D, Redfield J. Evaluation of the first 70 patients in the Center for Male Sexual Dysfunction of Beth Israel Medical Center. J Urol 1984; 131: 53–5
78. Horton CE, Sadove RC, Devine CJ Jr. Peyronie's disease. Ann Plast Surg 1987; 18: 122–7.
79. Karacan I. Clinical value of nocturnal erection in the prognosis and diagnosis of impotence. Med Aspects Hum Sex 1970; 4(4):27–34.
80. Fisher C, Gross J, Zuch J. Cycle of penile erections synchronous with dreaming (REM) sleep: preliminary report. Arch Gen Psychiatry 1965; 12: 29–45.
81. Karacan I, Salis PJ, Williams RL. The role of the sleep laboratory in diagnosis and treatment of impotence. In: Williams RL, ed. Sleep disorders: diagnosis and treatment. New York: John Wiley, 1978:351–82.
82. Procci WR, Martin DJ. Preliminary observations of the utility of portable NPT. Arch Sex Behav 1984; 13: 569–80.
83. Wein AJ, Fishkin R, Carpiniello VL, Malloy TR. Expansion without significant rigidity during nocturnal penile tumescence testing: a potential source of misinterpretation. J Urol 1981; 126: 343–4.
84. Marshall PG. Morales A, Phillips P, Fenemore J. Nocturnal penile tumescence with stamps: a comparative study under sleep laboratory conditions. J Urol 1983; 130: 88–9.
85. Barry JM, Blank B, Boileau M. Nocturnal penile tumescence monitoring with stamps. Urology 1980; 15: 171–2.
86. Anders EK, Bradley WE, Krane RJ. Nocturnal penile rigidity measured by the snap-gauge band. J Urol 1983; 129: 964–6.
87. Bradley WE, Timm GW, Gallagher JM, Johnson BK. New method for continuous measurement of nocturnal penile tumescence and rigidity. Urology 1985; 26: 4–9.
88. Karacan I. The dilemma of diagnosing erectile dysfunction. In: Carlton EC, ed. Controversies in urology. Chicago: Year Book, 1989:99–103.
89. Ware JC. Evaluation of impotence: monitoring periodic penile erections during sleep. Psychiatric Clin North Am 1987; 10: 675–86.
90. Ertekin C, Akjurekli O, Gruses AN, et al. The value of somatosensory-evoked potentials and bulbocavernous reflex in patients with impotence. Arch Neurol Scand 1985; 71: 48.
91. Newman HF. Vibratory sensitivity of the penis. Fertil Steril 1970; 21: 791–3.
92. Spratt DI, O'Dea LS, Schoenfeld D, Butler J, Rao PN, Crowley WF Jr. Neuroendocrine-gonadal axis in men: frequent sampling of LH, FSH, and testosterone. Am J Physiol 1988; 254: E658–E666.
93. Kedia KR. Vasculogenic impotence: diagnosis and objective evaluation using quantitative segmental pulse volume recorder. Br J Urol 1984; 56: 516–20.
94. Abelson D. Diagnostic value of the penile pulse and blood pressure: a Doppler study of impotence in diabetics. J Urol 1975; 113: 636–9.
95. Goldstein I, Siroky MB, Nath RL, McMillian TN, Menzoian JO, Krane RJ. Vasculogenic impotence: role of the pelvic steal test. J Urol 1982; 128: 300–6.
96. Abber JC, Lue TF. Evaluation of impotence. In: deVere White R, ed. Problems in urology: sexual dysfunction. Philadelphia: J.B. Lippincott, 1987:476–86.
97. Lue TF, Hricak H, Manch KW, Tanagho EA. Vasculogenic impotence evaluated by high-resolution ultrasonography and pulsed Doppler spectrum analysis. Radiology 1985; 155: 777–81.
98. Goldstein I. Vasculogenic impotence: its diagnosis and treatment. In: deVere White R, ed. Problems in urology: sexual dysfunction. Philadelphia: J.B. Lippincott, 1987:547–63.
99. Goldstein I. Overview of types and results of vascular surgical procedures for impotence. Cardiovasc Intervent Radiol 1988; 11: 240–4.
100. Zorgniotti AW, Padula G, Shaw WW. Selective arteriography for vascular impotence. World J Urol 1983; 1: 213–7.
101. Bookstein JJ, Valji K, Parsons L, Kessler W. Pharmacoarteriography in the evaluation of impotence. J Urol 1987; 137: 333–7.
102. Wespes E. Schulman CC. Venous leakage: surgical treatment of a curable cause of impotence. J Urol 1985; 133: 796–8.
103. Puyau FA, Lewis RW. Corpus cavernosography: pressure flow and radiography. Invest Radiol 1983; 18: 517–22.
104. Golden J. Behavioral approaches to the treatment of sexual problems. In: Zales MR, ed. Eating, sleeping and sexuality: treatment of disorders in basic life functions. New York: Brunner Mazel, 1982:236–57.
105. Masters WH, Johnson VE. Human sexual inadequacy. Boston: Little, Brown, 1970.
106. LoPiccolo J, Stock WE. Treatment of sexual dysfunction. J Consult Clin Psychol 1986; 54: 158–67.
107. Hengeveld MW. Erectile dysfunction: a sexological and psychiatric review. World J Urol 1983; 1: 227–32.
108. Wilson JD, Griffin JE. The use and misuse of androgens. Metabolism 1980; 29: 1278–95.
109. Snyder PJ. Lawrence DA. Treatment of male hypogonadism with testosterone enanthate. J Clin Endocrinol Metab 1980; 51: 1335–9.
110. Morales A, Condra M, Owen JA, Surridge DH, Fenemore J, Harris C. Is yohimbine effective in the treatment of organic impotence? Results of a controlled trial. J Urol 1987; 137: 1168–72.
111. Morales A, Condra MS, Owen JA, Fenemore J, Surridge DH. Oral and transcutaneous pharmacologic agents in the treatment of impotence. Urol Clin North Am 1988; 15: 87–93.
112. Juenemann K-P, Lue TF, Foumier GR Jr, Tanagho EA. Hemodynamics of papaverine- and phentolamine-induced penile erection. J Urol 1986; 136: 158–61.
113. Wyndaele JJ, De Meyer JM, de Sy WA, Claessens H. Intracavernous injection of vasoactive drugs, an alternative for treating impotence in spinal cord injury patients. Paraplegia 1986; 24: 271–5.
114. Buvat J, Buvat-Herbaut M, Dehaene JL, Lemaire A. Is intracavernous injection of papaverine a reliable screening test for vascular impotence? J Urol 1986; 135: 476–8.
115. Kiely EA, Williams G, Goldie L. Assessment of the immediate and long-term effects of pharmacologically induced penile erections in the treatment of psychogenic and organic impotence. Br J Urol 1987; 59: 164–9.
116. Padma-Nathan H, Goldstein I, Payton T, Krane RJ. Intracavernosal pharmacotherapy: the pharmacologic erection program. World J Urol 1987; 5: 160–5.
117. Virag R. Intracavernous injection of papaverine for erectile failure. Lancet 1982; 2: 938.
118. Brindley GS. Pilot experiments on the actions of drugs injected into the human corpus cavernosum penis. Br J Pharmacol 1986; 87: 495–500.
119. Trapp JD. Pharmacologic erection program for the treatment of male impotence. South Med J 1987; 80: 426–7.
120. Zorgniotti AW, Lefleur RS. Auto-injection of the corpus cavernosum with a vasoactive drug combination for vasculogenic impotence. J Urol 1985; 133: 39–41.
121. Stackl W, Hasun R, Marberger M. Intracavernous injection of prostaglandin E1 in impotent men. J Urol 1988; 140: 66–8.
122. Zentgraf M, Baccouche M, Juncmann KP. Diagnosis and therapy of erectile dysfunction using papaverine and phentolamine. Urol Int 1988; 43: 65–75.
123. Levine SB, Althof SE, Turner LA, et al. Side effects of self-administration of intracavernous papaverine and phentolamine for the treatment of impotence. J Urol 1989; 141: 54–7.
124. Lee LM. Stevenson RW, Szasz G. Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison. J Urol 1989; 141: 549–50.
125. Waldhauser M, Schramek P. Efficiency and side effects of prostaglandin E1 in the treatment of erectile dysfunction. J Urol 1988; 140: 525–7.
126. Dewar ML, Blundell PE, Lidstone D, Herba MJ, Chiu RC. Effects of abdominal aneurysmectomy, aortoiliac bypass grafting and angioplasty on male sexual potency: a prospective study. Can J Surg 1985; 28: 154–6, 159.
127. Michal V, Kramar R, Pospichal J, Hejhal L. Direct arterial anastomosis on corpora cavernosa penis in the therapy of erective impotence. Rozhl Chir 1973; 52: 587–90.
128. LeVeen HH. Vein graft for vascular impotence. Med World News 1978; 19: 73.
129. McDougal WS, Jeffery RF. Microscopic penile revascularization. J Urol 1983; 129: 517–21.
130. Sharlip ID. Treatment of arteriogenic impotence by penile revascularization. In: Proceedings of the Sixth Biennial International Symposium for Corpus Cavernosum Revascularization and Third Biennial World Meeting on Impotence. Boston, Massachusetts, October 6, 1988:135.
131. Virag R, Zwang G, Dermange H, Legman M. Vasculogenic impotence: a review of 92 cases with 54 surgical operations. Vasc Surg 1981; 15: 9–17.
132. Bennett AH. Venous arterialization for erectile impotence. Urol Clin North Am 1988; 15: 111–3.
133. Lewis RW, Puyau FA. Procedures for decreasing venous drainage. Semin Urol 1986; 4: 263–72.
134. Lue TF. Treatment of venogenic impotence. In: Tanagho EA, Lue TF, McClure RD, eds. Contemporary management of impotence and infertility. Baltimore: Williams & Wilkins, 1988:175–7.
135. Lewis RW. Venous surgery for impotence. Urol Clin North Am 1988: 15: 115–21.
136. Bar-Moshe O, Vandendris M. Treatment of impotence due to perineal venous leakage by ligation of crura penis. J Urol 1988; 139: 1217–9.
137. Glina S, Puech-Leao P, Reis JMSM, Reichelt achéal, Choa S. Surgical correction of corpora cavernosa leakage responsive to perineal compression: late results. In: Proceedings of the Sixth Biennial International Symposium for Corpus Cavernosum Revascularization and Third Biennial World Meeting on Impotence, Boston, Massachusetts, October 6, 1988:142.
138. Goodwin WE, Scott WW. Phalloplasty. J Urol 1952; 68: 903–8.
139. Small MP, Carrion HM. A new penile prosthesis for treating impotence: the developers of this implant discuss indications for its use and present their surgical technique. Contemp Surg 1975; 7: 29–33.
140. Scott FB, Bradley WE, Timm GW. Management of erectile impotence: use of implantable inflatable prosthesis. Urology 1973; 2: 80–2.
141. Gregory JG, Purcell MH. Scott's inflatable penile prosthesis: evaluation of mechanical survival in the series 700 model. J Urol 1987; 137: 676–7.
142. Malloy TR, Wein AJ, Carpiniello VL. Reliability of AMS M700 inflatable penile prosthesis. Urology 1986; 28: 385–7.
143. Thomalla JV, Thompson ST, Rowland RG, Mulcahy JJ. Infectious complications of penile prosthetic implants. J Urol 1987; 138: 65–7.
144. Carson CC. Infections in genitourinary prostheses. Urol Clin North Am 1989; 16: 139–47.
145. Kaufman JJ, Lindner A, Raz S. Complications of penile prosthesis surgery for impotence. J Urol 1982; 128: 1192–4.
146. Kessler R. Surgical experience with the inflatable penile prosthesis. J Urol 1980; 124: 611–2.
147. Furlow WL, Goldwasser B, Gundian JC. Implantation of model AMS 700 penile prosthesis: long-term results. J Urol 1988; 139: 741–2.
148. Witherington R. Vacuum constriction device for management of erectile impotence. J Urol 1989; 141: 320–2.
149. Witherington. Suction device therapy in the management of erectile impotence. Urol Clin North Am 1988; 15: 123–8.
150. Nadig PW, Ware JC, Blumoff R. Noninvasive device to produce and maintain an erection-like state. J Urol 1986; 27: 126–31.